Registrations are open for the 5th edition of the Monash Organoid Symposium!
This year again, it’s a free event open to all, don’t hesitate to share the flyer within your Institute and with your colleagues, collaborators and friends.
The poster session will run again this year with prizes to win and we have some exciting news: there are a few travel awards up for grabs! These will be attributed together with a spot to present in the ECR selected talk session.
To obtain a travel award+selected talk or a poster presentation it’s simple: submit your abstract before September 30th to eglantine.balland@monash.edu
You can find all the details about the event on the registration page, including the program and instructions to submit an abstract.
Please have a look at the FAQs on the registration page and if you have further questions, don’t hesitate to contact Eglantine Balland: eglantine.balland@monash.edu
Phenomics Australia provides a national centre of expertise and service provision to deploy a more comprehensive and sophisticated range of in vitro Genome Engineering and Disease Modelling capabilities to understand the functional consequences of DNA sequence variation in the human genome for health and disease while maintaining the expertise for in vivo disease modelling and genome engineering. To meet the high demand for adaptable and scalable disease-modelling platforms for improved diagnosis, Precision Medicine for genetic disorders, and therapeutic development by both academia and the biopharmaceutical industry, Phenomics Australia offers In Vitro services through a collaborative consortium of ten laboratories and facilities across Australia, operating at ANU (ANU Centre for Therapeutic Discovery), Perkins (Translational Cancer Research Program in Oncology), Monash (Monash Organoid Program & Monash Genome Modification Platform), MCRI (iPSC derivation & Gene Editing Facility), Peter Mac (Victorian Centre for Functional Genomics), UMelb (Centre for Stem Cell Systems & Stem Cell Disease Modelling Laboratory), UQ (In vitro Genome Engineering and Disease Modelling Service), and VCCRI (Stem Cell Production Facility iPSC Reprogramming Service)






